[go: up one dir, main page]

WO2002002771A3 - Nouveau gene hsparc-11 et procedes de fabrication et d'utilisation de ce dernier - Google Patents

Nouveau gene hsparc-11 et procedes de fabrication et d'utilisation de ce dernier Download PDF

Info

Publication number
WO2002002771A3
WO2002002771A3 PCT/US2001/014859 US0114859W WO0202771A3 WO 2002002771 A3 WO2002002771 A3 WO 2002002771A3 US 0114859 W US0114859 W US 0114859W WO 0202771 A3 WO0202771 A3 WO 0202771A3
Authority
WO
WIPO (PCT)
Prior art keywords
hsparc
methods
homologous
gene
human sparc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/014859
Other languages
English (en)
Other versions
WO2002002771A2 (fr
Inventor
Pamela Jean Mitchell
Rosamund Carol Smith
Eric Wen Su
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Priority to AU2001268053A priority Critical patent/AU2001268053A1/en
Publication of WO2002002771A2 publication Critical patent/WO2002002771A2/fr
Anticipated expiration legal-status Critical
Publication of WO2002002771A3 publication Critical patent/WO2002002771A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne au moins un nouveau polypeptide hSPARC-h1, des acides nucléiques isolés qui codent pour ces polypeptides, ainsi que des vecteurs, des cellules hôtes, des transgènes, des chimères, des procédés de fabrication et d'utilisation de ces derniers, des anticorps de hSPARC-h1 et des utilisations de ceux-ci.
PCT/US2001/014859 2000-07-05 2001-06-15 Nouveau gene hsparc-11 et procedes de fabrication et d'utilisation de ce dernier Ceased WO2002002771A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001268053A AU2001268053A1 (en) 2000-07-05 2001-06-15 Human sparc-homologous (hsparc-h1) gene and methods and uses thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21621600P 2000-07-05 2000-07-05
US60/216,216 2000-07-05

Publications (2)

Publication Number Publication Date
WO2002002771A2 WO2002002771A2 (fr) 2002-01-10
WO2002002771A3 true WO2002002771A3 (fr) 2003-01-23

Family

ID=22806217

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/014859 Ceased WO2002002771A2 (fr) 2000-07-05 2001-06-15 Nouveau gene hsparc-11 et procedes de fabrication et d'utilisation de ce dernier

Country Status (2)

Country Link
AU (1) AU2001268053A1 (fr)
WO (1) WO2002002771A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2561887B8 (fr) 2003-01-14 2016-12-21 Dana-Farber Cancer Institute, Inc. Sensibilisateur de thérapie anticancéreuse
AU2006249235B2 (en) 2004-05-14 2010-11-11 Abraxis Bioscience, Llc Sparc and methods of use thereof
US8420603B2 (en) 2004-05-14 2013-04-16 Abraxis Bioscience, Llc SPARC and methods of use thereof
US10703786B2 (en) * 2015-10-30 2020-07-07 The University Of Melbourne Methods and compositions for improving glucose metabolism
US20210262006A1 (en) * 2018-06-18 2021-08-26 Emory University Parallel Enzyme Digestion for Protein Biomarker Detection
US11691208B2 (en) 2018-10-27 2023-07-04 Ridge Tool Company Pipe cut-off tool and accessories for such tools

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999058675A2 (fr) * 1998-05-14 1999-11-18 Chiron Corporation Genes humains et produits d'expression genique v
WO2000061755A2 (fr) * 1999-04-09 2000-10-19 Chiron Corporation Proteines humaines secretees
WO2001053455A2 (fr) * 1999-12-23 2001-07-26 Hyseq, Inc. Nouveaux acides nucleiques et polypeptides associes
WO2001060850A1 (fr) * 2000-02-14 2001-08-23 Smithkline Beecham Corporation Nouveaux composes
WO2001079454A1 (fr) * 2000-04-13 2001-10-25 Smithkline Beecham Corporation Nouveaux composes
WO2002002603A2 (fr) * 2000-06-30 2002-01-10 Incyte Genomics, Inc. Molecules de modification et de maintenance de proteines

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999058675A2 (fr) * 1998-05-14 1999-11-18 Chiron Corporation Genes humains et produits d'expression genique v
WO2000061755A2 (fr) * 1999-04-09 2000-10-19 Chiron Corporation Proteines humaines secretees
WO2001053455A2 (fr) * 1999-12-23 2001-07-26 Hyseq, Inc. Nouveaux acides nucleiques et polypeptides associes
WO2001060850A1 (fr) * 2000-02-14 2001-08-23 Smithkline Beecham Corporation Nouveaux composes
WO2001079454A1 (fr) * 2000-04-13 2001-10-25 Smithkline Beecham Corporation Nouveaux composes
WO2002002603A2 (fr) * 2000-06-30 2002-01-10 Incyte Genomics, Inc. Molecules de modification et de maintenance de proteines

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 1 July 1999 (1999-07-01), XP002205641, Database accession no. AF070470 *
MOTAMED K: "SPARC (osteonectin/BM-40).", THE INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, vol. 31, no. 12, December 1999 (1999-12-01), pages 1363 - 1366, XP002205640, ISSN: 1357-2725 *

Also Published As

Publication number Publication date
AU2001268053A1 (en) 2002-01-14
WO2002002771A2 (fr) 2002-01-10

Similar Documents

Publication Publication Date Title
WO2004003147A3 (fr) Polypeptides cngh0004, anticorps, compositions, procedes et utilisations
WO2003089598A3 (fr) Polypeptides a activite xyloglucanase, et acides nucleiques codant ceux-ci
WO1998056927A3 (fr) Acides nucleiques codant des polypeptides a fonction protease
WO2001046420A8 (fr) Polypeptides homologues de l'il-17 et leurs utilisations therapeutiques
WO1999061469A3 (fr) Proteines de membrane associees a la croissance de la prostate
WO2003035847A3 (fr) Proteines muteines il-13, anticorps, compositions, procedes et utilisations
WO2001029222A3 (fr) Polypeptides ayant une activite phospholipase b et acides nucleiques codant ces derniers
WO2002006457A3 (fr) Genes de lipase
WO2002008277A3 (fr) Acides nucleiques, vecteurs, cellules hotes, polypeptides et leurs utilisations
WO2002062999A3 (fr) Proteines et acides nucleiques codant pour celles-ci
WO2002059315A3 (fr) Nouveaux acides nucleiques et polypeptides et procedes de leur utilisation
WO2002046409A3 (fr) Proteines et acides nucleiques les codant
WO2003038041A3 (fr) Mut-il-4: proteines, anticorps, compositions, procedes et utilisations
WO2002036627A3 (fr) Interferons, utilisations et compositions associees
WO2001098469A3 (fr) Polypeptides presentant une activite de la peroxydase et acides nucleiques codant pour ces polypeptides
WO2001090326A3 (fr) Nouvelles metalloproteinases matricielles
WO2002016611A3 (fr) Polypeptides d'interleukine-22, acides nucleiques codant pour lesdits polypeptides et methode permettant de traiter les affections pancreatiques
WO2000059942A3 (fr) COMPOSITIONS hOB-BP2h, LEURS TECHNIQUES ET LEURS UTILISATIONS
WO2002002771A3 (fr) Nouveau gene hsparc-11 et procedes de fabrication et d'utilisation de ce dernier
WO2002085922A3 (fr) Proteines et acides nucleiques codant pour celles-ci
WO2001092493A3 (fr) Nouvelles aminopeptidases humaines 21956 et 25856, et utilisations
WO2000039297A3 (fr) Polypeptides apparentes a il-1
WO2001083552A3 (fr) Acides nucleiques et polypeptides sez6 humains
WO2002090500A3 (fr) Nouvelles proteines humaines, polynucleotides codant ces proteines et methodes d'utilisation des proteines
WO2002046408A3 (fr) Nouvelles proteines humaines, polynucleotides les codant et procedes d'utilisation

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP